MS vs PRLD · P/E 20, $344.27B cap vs rev $6.5M
Morgan Stanley (MS) versus Prelude Therapeutics Inc (PRLD) — a side-by-side from cached financials, not a winner call.
Morgan Stanley (MS) is a capital markets company listed on US. It is led by Ted Pick.
Prelude Therapeutics Inc (PRLD) is a biotechnology company listed on NASDAQ.
MS does not have a complete income-statement cache yet.
Latest reported PRLD revenue for 2025-09-30 was $6.5M. Net income was -$83.0M. Revenue was up 116.7% from 2024-09-30 to 2025-09-30. PRLD currently screens at market cap $346.5M.
MS currently screens at market cap $344.27B and trailing P/E 19.8. PRLD currently screens at market cap $346.5M.
Not investment advice. Open the MS and PRLD stock pages for the full models.
Not investment advice.